Scenarios that move ALNY
Alnylam Pharmaceuticals, Inc. - Common Stock
Scenarios that move ALNY: 8 analyses, 3 positive, 5 negative.
- · Ascendis Pharma receives positive CHMP opinion for TransCon CNP — ▲ · impact +6 · confidence low · horizon weeks
- · Mirum's Livmarli meets Phase III goal in ultra-rare liver diseases — ▼ · impact -25 · confidence low · horizon quarters
- · Novartis acquires Abogen in $7.8B RNA therapeutics deal — ▲ · impact +40 · confidence medium · horizon immediate
- · uniQure plunges after additional Huntington's disease study data — ▲ · impact +15 · confidence low · horizon weeks
- · Mirum's Brelovitug meets goal in Phase III AZURE-1 study — ▼ · impact -12 · confidence low · horizon quarters
- · ADARx Pharmaceuticals prices upsized $446.3 million initial public offering — ▼ · impact -35 · confidence low · horizon quarters
- · Ionis reports positive late-stage results for two partnered drugs — ▼ · impact -60 · confidence medium · horizon weeks
- · Amgen shares fall after Novartis' Pelacarsen misses Phase III goal — ▼ · impact -35 · confidence medium · horizon weeks